NCT00265811View on ClinicalTrials.gov

Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

2,559

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2009

Study Completion Date

June 22, 2010

Conditions
Colorectal Cancer
Interventions
DRUG

Folfox

DRUG

Cetuximab

Trial Locations (8)

14033

CHU de Caen, Caen

26000

Nouvelle Clinique Generale, Valence

33500

Hopital Robert Boulin, Libourne

75018

Hopital Bichat - Claude Bernard, Paris

75651

CHU Pitie-Salpetriere, Paris

75970

Hopital Tenon, Paris

84902

Hopital Duffaut, Avignon

BP 2367

Centre Hospitalier Yves Le Foll, Saint-Brieuc

All Listed Sponsors
lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT00265811 - Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery | Biotech Hunter | Biotech Hunter